fda compounding glp-1 enforcement news november 2025 Compounded" drugs | Health Communication Research Laboratory Report: FDA must enforce rules

The company has acquired a European competitor, Zava, which already has 1.3 million customers for a range of productsincluding some obesity treatmentsin the UK, Ireland, Germany and France

Learn how injection timing affects side effects, what FDA guidelines say, and practical tips for consistent dosing to maximize your weight loss results with this once-weekly medication.

Breastfeeding mothers seeking weight loss face a critical decision: GLP-1 medications like Wegovy transfer into breast milk, and limited safety data exists for nursing infants

iron: 12% of the DV

Theres a gap right now between what we see in the headlines and what patients are actually experiencing

Mark Hyman explains why that doesnt always reflect wellness, and what early signals can be missed over time.